The authors declare that they have no competing interests. Authors’ contributions All co-authors have made substantive intellectual contributions to the paper as follows: KGS, TLS, and PTY designed and implemented the DataPall software; created and carried out the study of its effectiveness; analyzed the data; and drafted the manuscript. AK and SG provided substantive input on the design and

functionality of the DataPall software and revised the manuscript. RRK and MO oversaw the work of the team creating DataPall; advised the design of the study; and Inhibitors,research,lifescience,medical provided critical insights and revisions to the manuscript. RRK had full access to all of the data in the Inhibitors,research,lifescience,medical study and takes responsibility for the integrity of the data and the accuracy of the data analysis. All authors read and approved the final manuscript. Pre-publication history The pre-publication history for this paper can be accessed here: http://www.biomedcentral.com/1472-684X/12/31/prepub

Supplementary Material Additional file 1: A generic copy of the DataPall EMR. Click here for file(3.2M, mdb) Additional file 2: Sample DataPall Palliative Care Inhibitors,research,lifescience,medical Report output by the DataPall EMR. Click here for file(301K, pdf) Acknowledgements This work was supported in part by a grant to Rice University from the Howard Hughes Medical Institute through the Undergraduate Science Education Program. This grant supported the work of KGS, TLS, and PTY in Malawi, where the DataPall system was designed, implemented, Inhibitors,research,lifescience,medical and tested.
The Selleckchem PS341 prevalence of dementia worldwide is significantly growing, with the majority of the persons

with dementia dying in nursing homes [1,2]. Therefore, the provision of high-quality end-of-life care for nursing home residents with dementia is essential [3-6]. However, the literature reports numerous Inhibitors,research,lifescience,medical shortcomings in the end-of-life care for dementia, suffering of residents and unfulfilled needs of families [6]. For example, an Italian study reported high levels of pressure ulcers, burdensome interventions such as tube- and PEG-feeding, psychotropic drugs and poor decision-making in why the last month of life of nursing home residents with dementia [7]. Despite some encouraging trends from The Netherlands and the U.S. regarding improved symptom management in dementia [8-10], improvement of end-of-life care for dementia remains a research priority [11]. Systematic assessments of care performance that are compared to professional targets or standards (hereafter referred to as audit and feedback) is widely used as a strategy to improve professional care practice [12]. In the nursing home setting, there are indications that audit and feedback using cumulative quality of care scores based on a group of patients may improve nursing home care in general [13-15], including nursing home care for residents with dementia [16].